DNT/gamma-delta

Optimal result: 0.2 – 4.3 %

Elevation of "DNT/gamma-delta" T cells can be triggered by various factors that activate the immune system or indicate an underlying pathological condition. Here are some common triggers for the elevation of these cells:

  1. Infections: Both bacterial and viral infections can lead to an increase in gamma-delta T cells, as these cells are capable of recognizing and responding rapidly to microbial antigens. They play a critical role in early immune defense, particularly in mucosal surfaces like the gut and lungs, where they can respond to pathogens without the need for antigen processing by other immune cells.

  2. Cancer: Elevated levels of gamma-delta T cells, including double-negative (DNT) gamma-delta T cells, can be seen in response to malignancies. These cells can recognize and kill tumor cells, often without the need for conventional antigen presentation. Their elevation may reflect the immune system's attempt to combat or control cancerous growths.

  3. Autoimmune Diseases: In autoimmune conditions, where the immune system attacks the body’s own tissues, gamma-delta T cells can become elevated as part of the inflammatory response. These cells might be involved in both the promotion and regulation of autoimmune processes, depending on the context and specific disease.

  4. Chronic Inflammation: Conditions characterized by chronic inflammation, such as rheumatoid arthritis, inflammatory bowel disease, or chronic obstructive pulmonary disease (COPD), can lead to increased levels of gamma-delta T cells. Their role in inflammation and tissue repair can contribute to their elevated presence in these disorders.

  5. Stress and Tissue Damage: Physical trauma, surgical procedures, or other forms of tissue damage can trigger the activation and elevation of gamma-delta T cells. These cells respond to stress signals from damaged or dying cells and are involved in the repair processes, helping to restore tissue integrity.

  6. Immunological Dysregulation: Situations involving immune dysregulation, such as immunodeficiencies or after immunosuppressive treatments (e.g., organ transplantation, chemotherapy), can result in elevated gamma-delta T cells. This elevation might be a compensatory response to maintain immune surveillance and protect against infections or malignancies.

  7. Vaccine Responses: Certain vaccines, especially those targeting pathogens that involve mucosal immunity, can lead to the activation and elevation of gamma-delta T cells. This response is part of the broader immune activation aimed at providing protection against future infections.

These triggers reflect the diverse roles that gamma-delta T cells play in immune surveillance, inflammation, and tissue repair. Monitoring their levels can offer valuable insights into immune status and the presence of underlying diseases or immune responses.

Lowering levels of double-negative T cells (DNTs), including gamma-delta T cells, typically depends on addressing the underlying cause of their elevation. Here are some strategies that can help reduce DNT levels, focusing on underlying triggers and specific treatments:

  1. Treating Underlying Infections: Since infections can trigger elevated DNT levels, effective treatment of the underlying bacterial, viral, or fungal infection can help normalize these cell levels. This may involve antibiotics, antiviral medications, or antifungal treatments, depending on the specific pathogen.

  2. Managing Autoimmune Diseases: In cases where elevated DNT levels are associated with autoimmune conditions, managing the autoimmune response is key. Immunosuppressive drugs such as corticosteroids, methotrexate, or biologics (e.g., TNF inhibitors) can help reduce immune activation, thereby lowering DNT levels. Treatment plans should be tailored to the specific autoimmune disease and patient needs.

  3. Reducing Chronic Inflammation: For conditions characterized by chronic inflammation, such as rheumatoid arthritis, inflammatory bowel disease, or chronic obstructive pulmonary disease (COPD), using anti-inflammatory medications can help. Non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or other anti-inflammatory agents can reduce the overall inflammatory state and potentially lower DNT levels.

  4. Cancer Treatment: If elevated DNT levels are related to cancer, treating the underlying malignancy can be crucial. Treatments such as chemotherapy, radiation therapy, targeted therapy, or immunotherapy can help reduce tumor burden and, consequently, the immune response, including DNT cell levels.

  5. Stress Management and Lifestyle Changes: Since physical and psychological stress can elevate DNT levels, stress management techniques such as mindfulness, meditation, exercise, and proper sleep hygiene can help. Reducing overall stress levels may help modulate the immune response and lower DNT levels.

  6. Monitoring and Adjusting Immunosuppressive Therapy: In cases where immunosuppressive therapy (e.g., after organ transplantation) leads to immune dysregulation and elevated DNT levels, careful monitoring and adjustment of immunosuppressive medications might be necessary. Finding the right balance to prevent rejection while avoiding excessive immune activation is crucial.

  7. Use of Targeted Therapies: In specific cases, targeted therapies that directly modulate the function or proliferation of T cells may be used. This could include monoclonal antibodies or small molecule inhibitors designed to target specific pathways involved in T cell activation and proliferation.

  8. Nutritional and Lifestyle Interventions: A balanced diet rich in anti-inflammatory foods, regular physical activity, and avoiding smoking and excessive alcohol consumption can help maintain overall immune health and potentially reduce elevated DNT levels.

It is important to note that the approach to lowering DNT levels should be guided by a healthcare professional, based on a thorough evaluation of the underlying condition, the patient's overall health, and other relevant factors. Each patient may require a tailored approach to effectively manage elevated DNT levels.

The marker "DNT/gamma-delta" on a T Cell Monitoring & Activation panel refers to a unique subset of T cells that lack both CD4 and CD8 coreceptors (thus termed "double-negative T cells" or DNTs) and express the gamma-delta T cell receptor (TCR). Gamma-delta T cells are distinct from the more common alpha-beta T cells found in the adaptive immune system. They play an important role in bridging innate and adaptive immunity. Unlike alpha-beta T cells, which recognize antigens presented by major histocompatibility complex (MHC) molecules, gamma-delta T cells can recognize a wide range of antigens, including non-peptide antigens, lipid antigens, and even stressed or damaged self-cells without the need for antigen processing and presentation. This ability allows them to respond rapidly to infection and cellular stress, making them crucial in early immune responses against pathogens, tumors, and other abnormalities. DNTs, especially those expressing the gamma-delta TCR, are involved in maintaining immune homeostasis, promoting tissue repair, and regulating inflammation. Elevated levels of DNT/gamma-delta T cells can indicate an active response to infection, inflammation, or malignancy. Conversely, aberrant regulation or depletion of these cells has been linked to autoimmune diseases, chronic inflammation, and impaired immune surveillance. Therefore, monitoring the levels and activation status of DNT/gamma-delta T cells can provide valuable insights into the state of the immune system, potential infections, inflammatory conditions, and cancerous processes, making them a critical component of comprehensive T cell monitoring panels.

DNT/gamma-delta
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond DNT/gamma-delta — 10,000+ markers explained
One DNT/gamma-delta result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro